Страна: Великобритания
Език: английски
Източник: MHRA (Medicines & Healthcare Products Regulatory Agency)
Guaifenesin; Phenylephrine hydrochloride; Paracetamol
Haleon UK Ltd
N02BE51
Guaifenesin; Phenylephrine hydrochloride; Paracetamol
200mg ; 12.2mg ; 1gram
Powder for oral solution
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: ; GTIN: 5000347045110
PHARMA CODE REF. NO. 1403 PHARMA CODE REF. NO. 1403 _HOT CRANBERRY & BLACKCURRANT_ _Powder For Oral Solution_ _PARACETAMOL, PHENYLEPHRINE, GUAIFENESIN_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU TAKE THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION YOU NEED TO KNOW. This medicine is available without prescription, however you still need to use this product carefully to get the best results from it. • Keep this leaflet as you may need to read it again. • Ask your pharmacist if you need more information or advice. 1. What is this medicine and what is it used for? THIS MEDICINE CONTAINS: • PARACETAMOL which is a pain reliever (analgesic) and helps reduce your temperature when you have a fever • GUAIFENESIN which is an expectorant to help loosen phlegm • PHENYLEPHRINE which is a decongestant to reduce swelling in the passages of the nose to help you breathe more easily This medicine provides relief from the symptoms of colds and flu with chesty cough, including feverishness and chills, headache, sore throat pain, aches and pains, nasal congestion, sinusitis and its associated pain, and acute nasal catarrh. 2. Is this medicine suitable for you? DO NOT TAKE THIS MEDICINE: • if you are ALLERGIC to paracetamol, guaifenesin, phenylephrine or any of the other ingredients (see section 6) • if you have KIDNEY or LIVER PROBLEMS (including alcoholic liver disease), OVERACTIVE THYROID, DIABETES, HIGH BLOOD PRESSURE or HEART DISEASE • if you have GLAUCOMA or PHAEOCHROMOCYTOMA • if you are taking BETA BLOCKERS (e.g. atenolol), TRICYCLIC ANTIDEPRESSANTS (e.g. imipramine or amitriptyline) or if you are taking or have taken in the last TWO WEEKS MONOAMINE OXIDASE INHIBITORS (MAOIs) prescribed for DEPRESSION. DO NOT TAKE ANYTHING ELSE CONTAINING PARACETAMOL WHILE TAKING THIS MEDICINE. DO NOT TAKE WITH ANY OTHER FLU, COLD, DECONGESTANT PRODUCTS OR COUGH SUPPRESSANTS. TAKE SPECIAL CARE WITH THIS MEDICINE • This medicine may cause dizziness. If affected do not drive or operate machinery. ASK YOUR DOCTOR BEF Прочетете целия документ
OBJECT 1 BEECHAMS MAX STRENGTH ALL IN ONE HOT CRANBERRY AND BLACKCURRANT POWDER FOR ORAL SOLUTION Summary of Product Characteristics Updated 27-Jun-2016 | GlaxoSmithKline Consumer Healthcare 1. Name of the medicinal product Beechams Max Strength All in One Hot Cranberry and Blackcurrant, powder for oral solution 2. Qualitative and quantitative composition Each single-dose sachet contains paracetamol 1000 mg, guaifenesin 200 mg and phenylephrine hydrochloride 12.2 mg. Excipients: For a full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for oral solution. Grey to purple fine powder with a cranberry odour. 4. Clinical particulars 4.1 Therapeutic indications This product is indicated in adults and children aged 16 years and older for the short-term relief of the symptoms of influenza, feverishness, chills and colds including headache, chesty cough, sore throat pain, aches and pains, nasal congestion, sinusitis and its associated pain, and acute nasal catarrh. 4.2 Posology and method of administration POSOLOGY ADULTS (INCLUDING THE ELDERLY) AND CHILDREN AGED 16 YEARS AND OVER: One sachet, dissolved in a standard mug of hot water but not boiling water (approximately 250 ml), to be taken every four to six hours, up to a maximum of four sachets in any 24 hours. Minimum dosing interval: four hours Do not exceed the stated dose. Maximum duration of continued use without medical advice: 7 days. PAEDIATRIC POPULATION CHILDREN UNDER 16 YEARS OF AGE: Not to be given to children under 16 years of age, except under medical advice. The safety of this product in children aged from birth to 16 years of age has not been established (see section 5.1). No data are available. POPULATIONS PATIENTS WITH HEPATIC IMPAIRMENT: Patients who have been diagnosed with hepatic impairment must seek medical advice before taking this medicine. The restrictions related to the use of such combinations in patients with hepatic impairment are primarily a consequence of the paracetamol content of the product (see Section 4.4 Special Прочетете целия документ